作者: J. S. Andersen , C. R. Bridges , W. A. Anderson , M. A. Acker , R. L. Hammond
DOI: 10.1007/978-3-642-74404-4_44
关键词:
摘要: Currently, the patient with end-stage heart failure has few therapeutic options. These include cardiac transplantation, mechanical assist devices, and medical therapy only. Despite recent advances in all types of treatment, ideal for a failing yet to be offered. Such an option should provide independence from external attachments, allow immunocompetent host, minimize effects associated blood-surface interaction. Cardiac devices powered by skeletal muscle might meet these requirements.